Advertisement

International Orthopaedics

, Volume 43, Issue 8, pp 1787–1792 | Cite as

Infection safety of dexamethasone in total hip and total knee arthroplasty: a study of eighteen thousand, eight hundred and seventy two operations

  • Markku A. VuorinenEmail author
  • Riku A. Palanne
  • Tatu J. Mäkinen
  • Jarkko T. Leskinen
  • Heini Huhtala
  • Kaisa A. Huotari
Original Paper

Abstract

Purpose

Dexamethasone has been shown to prevent post-operative nausea and vomiting (PONV) and seems to reduce post-operative pain. Both factors, which can extend the hospital stay, delay rehabilitation, and impact patient satisfaction. Because of the immunosuppressive and glucose-rising effects of dexamethasone, there has been concern of its safety in arthroplasty surgery. The purpose of our study was to examine infection safety of dexamethasone in arthroplasty surgery with enough large study material to reliably detect a possible, even small, difference in infection incidence.

Methods

A total of 18,872 consecutive primary and revision hip and knee arthroplasties were analyzed with data gathered from clinical information databases and a surgical site infection surveillance database with prospective data collection. Also, emergency operations due to fractures were included except for hip hemiarthroplasties.

Results

During the follow-up, 189 (1.0%) prosthetic joint infections (PJIs) occurred: 0.8% after primary arthroplasty and 1.9% after revision arthroplasty. Dexamethasone was used in 2922 (15.5%) operations. The PJI rate in the dexamethasone group was 1.1% (31/2922) and in the non-dexamethasone group 1.0% (161/15950), with no significant difference in the risk of PJI between the two groups (OR 1.052, 95% CI 0.715–1.548, P = 0.773).

Conclusions

In our study material, the use of a single 5–10 mg dose of dexamethasone did not increase the incidence of post-operative PJI. A low dose of dexamethasone may be safely used to prevent PONV and as part of multimodal analgesia on patients undergoing arthroplasty operation.

Keywords

Prosthetic joint infection Infection Corticosteroid Risk factor PONV Postoperative nausea 

Notes

Funding

This study received a grant from the research fund of the Department of Orthopedics and Traumatology, Helsinki University Hospital (grant no. EVO 2/2017).

Compliance with ethical standards

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For this type of study, formal consent is not required. This article does not contain any studies with animals performed by any of the authors.

Conflict of interest

The authors declare that they have no conflicts of interest.

References

  1. 1.
    Kurtz SM, Ong KL, Lau E, Bozic KJ (2014) Impact of the economic downturn on total joint replacement demand in the United States: updated projections to 2021. J Bone Joint Surg Am 96:624–630.  https://doi.org/10.2106/JBJS.M.00285 CrossRefGoogle Scholar
  2. 2.
    Inacio MCS, Paxton EW, Graves SE, Namba RS, Nemes S (2017) Projected increase in total knee arthroplasty in the United States - an alternative projection model. Osteoarthr Cartil.  https://doi.org/10.1016/j.joca.2017.07.022
  3. 3.
    Parvizi J, Bloomfield MR (2013) Multimodal pain management in orthopedics: implications for joint arthroplasty surgery. Orthopedics 36:7–14.  https://doi.org/10.3928/01477447-20130122-51 CrossRefGoogle Scholar
  4. 4.
    Apfel CC, Korttila K, Abdalla M, Kerger H, Turan A, Vedder I et al (2004) A factorial trial of six interventions for the prevention of postoperative nausea and vomiting. N Engl J Med 350:2441–2451.  https://doi.org/10.1056/NEJMoa032196 CrossRefGoogle Scholar
  5. 5.
    Chu CC, Hsing CH, Shieh JP, Chien CC, Ho CM, Wang JJ (2014) The cellular mechanisms of the antiemetic action of dexamethasone and related glucocorticoids against vomiting. Eur J Pharmacol 722:48–54.  https://doi.org/10.1016/j.ejphar.2013.10.008 CrossRefGoogle Scholar
  6. 6.
    Waldron NH, Jones CA, Gan TJ, Allen TK, Habib AS (2013) Impact of perioperative dexamethasone on postoperative analgesia and side-effects: systematic review and meta-analysis. Br J Anaesth 110:191–200.  https://doi.org/10.1093/bja/aes431 CrossRefGoogle Scholar
  7. 7.
    De Oliveira GS, Jr AMD, Benzon HT, McCarthy RJ (2011) Perioperative single dose systemic dexamethasone for postoperative pain: a meta-analysis of randomized controlled trials. Anesthesiology 115:575–588.  https://doi.org/10.1097/ALN.0b013e31822a24c2 CrossRefGoogle Scholar
  8. 8.
    Andersen R, Krohg K (1976) Pain as a major cause of postoperative nausea. Can Anaesth Soc J 23:366–369CrossRefGoogle Scholar
  9. 9.
    De Oliveira GS, Jr C-ALJ, Ahmad S, Kendall MC, McCarthy RJ (2013) Dexamethasone to prevent postoperative nausea and vomiting: an updated meta-analysis of randomized controlled trials. Anesth Analg 116:58–74.  https://doi.org/10.1213/ANE.0b013e31826f0a0a CrossRefGoogle Scholar
  10. 10.
    Chirca I, Marculescu C (2017) Prevention of infection in orthopedic prosthetic surgery. Infect Dis Clin N Am 31:253–263.  https://doi.org/10.1016/j.idc.2017.01.011 CrossRefGoogle Scholar
  11. 11.
    Tande AJ, Patel R (2014) Prosthetic joint infection. Clin Microbiol Rev 27:302–345.  https://doi.org/10.1128/CMR.00111-13 CrossRefGoogle Scholar
  12. 12.
    Schacke H, Docke WD, Asadullah K (2002) Mechanisms involved in the side effects of glucocorticoids. Pharmacol Ther 96:23–43CrossRefGoogle Scholar
  13. 13.
    Salerno A, Hermann R (2006) Efficacy and safety of steroid use for postoperative pain relief: update and review of the medical literature. J Bone Joint Surg Am 88:1361–1372.  https://doi.org/10.2106/JBJS.D.03018 CrossRefGoogle Scholar
  14. 14.
    Backes JR, Bentley JC, Politi JR, Chambers BT (2013) Dexamethasone reduces length of hospitalization and improves postoperative pain and nausea after total joint arthroplasty: a prospective, randomized controlled trial. J Arthroplasty 28:11–17.  https://doi.org/10.1016/j.arth.2013.05.041 CrossRefGoogle Scholar
  15. 15.
    Koh IJ, Chang CB, Lee JH, Jeon YT, Kim TK (2013) Preemptive low-dose dexamethasone reduces postoperative emesis and pain after TKA: a randomized controlled study. Clin Orthop Relat Res 471:3010–3020.  https://doi.org/10.1007/s11999-013-3032-5 CrossRefGoogle Scholar
  16. 16.
    Lei YT, Xu B, Xie XW, Xie JW, Huang Q, Pei FX (2018) The efficacy and safety of two low-dose peri-operative dexamethasone on pain and recovery following total hip arthroplasty: a randomized controlled trial. Int Orthop 42:499–505.  https://doi.org/10.1007/s00264-017-3537-8 CrossRefGoogle Scholar
  17. 17.
    Xu B, Ma J, Huang Q, Huang ZY, Zhang SY, Pei FX (2017) Two doses of low-dose perioperative dexamethasone improve the clinical outcome after total knee arthroplasty: a randomized controlled study. Knee Surg Sports Traumatol Arthrosc.  https://doi.org/10.1007/s00167-017-4506-x
  18. 18.
    Hartman J, Khanna V, Habib A, Farrokhyar F, Memon M, Adili A (2017) Perioperative systemic glucocorticoids in total hip and knee arthroplasty: a systematic review of outcomes. J Orthop 14:294–301.  https://doi.org/10.1016/j.jor.2017.03.012 CrossRefGoogle Scholar
  19. 19.
    Li X, Sun Z, Han C, He L, Wang B (2017) A systematic review and meta-analysis of intravenous glucocorticoids for acute pain following total hip arthroplasty. Medicine (Baltimore) 96:e6872.  https://doi.org/10.1097/MD.0000000000006872 CrossRefGoogle Scholar
  20. 20.
    Meng J, Li L (2017) The efficiency and safety of dexamethasone for pain control in total joint arthroplasty: a meta-analysis of randomized controlled trials. Medicine (Baltimore) 96:e7126.  https://doi.org/10.1097/MD.0000000000007126 CrossRefGoogle Scholar
  21. 21.
    Richardson AB, Bala A, Wellman SS, Attarian DE, Bolognesi MP, Grant SA (2016) Perioperative dexamethasone administration does not increase the incidence of postoperative infection in total hip and knee arthroplasty: a retrospective analysis. J Arthroplast 31:1784–1787.  https://doi.org/10.1016/j.arth.2016.01.028 CrossRefGoogle Scholar
  22. 22.
    Kurtz SM, Lau E, Watson H, Schmier JK, Parvizi J (2012) Economic burden of periprosthetic joint infection in the United States. J Arthroplasty 27 e1:61–65.  https://doi.org/10.1016/j.arth.2012.02.022 CrossRefGoogle Scholar
  23. 23.
    Huotari K, Lyytikainen O, Team HIS (2006) Impact of postdischarge surveillance on the rate of surgical site infection after orthopedic surgery. Infect Control Hosp Epidemiol 27:1324–1329.  https://doi.org/10.1086/509840 CrossRefGoogle Scholar
  24. 24.
    Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori TG (1992) CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol 13:606–608CrossRefGoogle Scholar
  25. 25.
    Zmistowski B, Della Valle C, Bauer TW, Malizos KN, Alavi A, Bedair H et al (2014) Diagnosis of periprosthetic joint infection. J Orthop Res 32:98–107.  https://doi.org/10.1002/jor.22553 CrossRefGoogle Scholar
  26. 26.
    Zimmerli W, Trampuz A, Ochsner PE (2004) Prosthetic-joint infections. N Engl J Med 351:1645–1654.  https://doi.org/10.1056/NEJMra040181 CrossRefGoogle Scholar

Copyright information

© SICOT aisbl 2018

Authors and Affiliations

  1. 1.Department of Orthopedics and TraumatologyHelsinki University Hospital and University of HelsinkiHelsinkiFinland
  2. 2.Peijas Hospital, Department of Anaesthesiology, Intensive Care and Pain Medicine, Helsinki University HospitalUniversity of HelsinkiVantaaFinland
  3. 3.Faculty of Social SciencesUniversity of TampereTampereFinland
  4. 4.Department of Infectious DiseasesHelsinki University Hospital and University of HelsinkiHelsinkiFinland

Personalised recommendations